Cambridge, UK: o2h Ventures is thrilled to announce that we have been recognized as a finalist at the Growth Investor Awards 2023 for the ‘Best EIS Manager – Specialist’ category for the second consecutive year.
The category acknowledges and celebrates outstanding investment managers in EIS (Enterprise Investment Schemes) with a specialist focus on a particular area of underlying investments. The evaluation was based on assessing the success across business performance, investment inflows, impact on investors, adviser relations, customer feedback, and overall impact.
As a leading biotech specialist tax-efficient fund manager, we are dedicated to supporting and nurturing early-stage biotech companies in the United Kingdom. Our two offerings are the o2h human health SEIS fund and the human health Knowledge Intensive EIS fund. To gain a comprehensive understanding of our unique fund offerings, please visit o2hventures.com/funds.
Our unwavering commitment has been to diligently curate a robust and diverse s/eis portfolio within the biotech sector for our valued investors. For a deeper understanding of our portfolio, we invite you to explore our portfolio companies at o2hventures.com/portfolio
About the Growth Investor Awards 2023
Celebrating the role of the UK SME investment community in job and wealth creation, the Growth Investor Awards recognise those enabling start up and ‘scale up’ businesses to realise their full potential and drive Britain’s economic recovery.
Open to both companies and individuals, these awards honour all those involved in putting investment to work in high potential businesses – from those providing investment or helping to source it to those best optimising growth capital to scale.
To learn more about Growth Investor Awards, please visit, https://growthinvestorawards.com/